Connect with us

Business

Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s

Published

on

Eli Lilly and Novo Nordisk stocks fall as Trump says he wants 0 price for GLP-1s


Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150 per month, a fraction of their current list price.

“In London, you’d buy a certain drug for $130 and even less than that … $88 as of… a month ago. And in New York, you pay $1,300 for the same thing,” Trump said during a Thursday afternoon event about in vitro fertilization at the White House. “Instead of $1,300 you’ll be paying about $150 and they’ll be paying $150 so we’re going to pay the same thing.”

Asked by a reporter what drug he was referring to, Trump replied, “I was referring to Ozempic or … the fat loss drug.”

At that point, Centers for Medicare and Medicaid Administrator Dr. Mehmet Oz interjected and stressed that the administration has not yet agreed to GLP-1 price reductions with drugmakers.

“We have not negotiated those yet … We’re going to be rolling these out over time, the GLP category of drugs, which includes Ozempic have not been negotiated yet,” Oz said.

Just a week ago, Oz had said that the administration was “in the middle of a lot of action” with price discussions with weight loss drugmakers.

CMS Administrator Dr. Oz on GLP-1 for weight loss in Medicare: You’ll be hearing more soon

Eli Lilly shares closed 2% lower Friday, while Novo Nordisk’s stock fell 3% in U.S. trading. Meanwhile, shares of Hims & Hers Health — which sells much cheaper compounded GLP-1s — plunged more than 15%.

Eli Lilly and Novo Nordisk were among 17 of the largest U.S. pharmaceutical companies that received letters from the Trump administration following the president’s executive order on so-called most-favored nation pricing, demanding that businesses bring U.S. drug prices in line with those in other developed nations.

Pfizer and AstraZeneca have signed on to the president’s initiative, striking drug pricing deals with the administration. But Trump and Oz’s comments make it clear the administration is looking to get the weight loss drugmakers on board.

$150 GLP-1 would be cheaper than compounders

While demand for weight loss drugs has grown, price has remained an obstacle for consumers and employers.

Only about one in five large employers currently offer GLP-1s for weight loss, according to a new survey from the Kaiser Family Foundation. Of those who do, two-thirds say the high cost drugs have had a “significant” impact on their prescription drug spending.

Workers who don’t get coverage through health insurance have increasingly turned to the cash market to buy the drugs on their own.

Eli Lilly and Novo Nordisk sell discounted versions of their diabetes and weight loss medications on their direct-to-consumer sites at roughly $500 a month. Telehealth providers like Hims & Hers offer compounded versions of GLP-1s for less than half that price, anywhere between $130 to $200 per month.

If the administration could bring the cash price for popular weight loss drugs like Lilly’s Zepbound and Novo Nordisk’s Wegovy down to $150, that would be competitive with compounded options and could have a major impact on the current cash market.



Source link

Business

Stock market today: Which are the top losers and gainers on March 6- check list – The Times of India

Published

on

Stock market today: Which are the top losers and gainers on March 6- check list – The Times of India


Benchmark equity indices Sensex and Nifty fell sharply on Friday, retreating by more than 1 per cent after a brief recovery in the previous session as escalating tensions in West Asia and surging crude oil prices weighed on investor sentiment.The 30-share BSE Sensex declined 1,097 points, or 1.37 per cent, to close at 78,918.90. During the session, it had plunged 1,203.72 points, or 1.50 per cent, to 78,812.18. The NSE Nifty dropped 315.45 points, or 1.27 per cent, to settle at 24,450.45.

Nifty50 top gainers

  • Bharat Electronics (1.84%)
  • Reliance Industries (1.11%)
  • ONGC (0.95%)
  • Sun Pharma (0.84%)
  • NTPC (0.68%)
  • Hindalco (0.42%)
  • HCL Tech (0.20%)
  • Infosys (0.20%)
  • Bajaj Auto (0.12%)
  • Nestle India (0.12%)

Nifty50 top losers

  • ICICI Bank (-3.26%)
  • Eternal (-3.16%)
  • Shriram Finance (-3.08%)
  • Axis Bank (-2.47%)
  • UltraTech Cement (-2.45%)
  • Kwality Wall’s (-2.42%)
  • InterGlobe Aviation (-2.41%)
  • Adani Enterprises (-2.36%)
  • HDFC Bank (-2.36%)
  • HDFC Life (-2.31%)

BSE Sensex top gainers

  • Bharat Electronics (1.84%)
  • Reliance Industries (1.11%)
  • Sun Pharma (0.84%)
  • NTPC (0.68%)
  • HCL Tech (0.20%)
  • Infosys (0.20%)

BSE Sensex top losers

  • ICICI Bank (-3.26%)
  • Eternal (-3.16%)
  • Axis Bank (-2.47%)
  • UltraTech Cem. (-2.45%)
  • Kwality Wall’s (-2.42%)
  • InterGlobe (-2.41%)
  • HDFC Bank (-2.36%)
  • SBI (-2.27%)
  • Bajaj Finserv (-2.25%)
  • L&T (-2.21%)

The decline came as Brent crude, the global oil benchmark, jumped 2.53 per cent to $87.57 per barrel, raising concerns about inflation and macroeconomic stability.“Indian equity markets extended their decline following the prior session’s relief rally, as escalating US-Iran tensions disrupted key Middle Eastern oil and gas supplies, driving crude prices higher. A sustained rise in oil prices could weigh on investor sentiment and adversely affect India’s twin deficits, inflation trajectory, and the RBI’s monetary stance,” said Vinod Nair, Head of Research, Geojit Investments Ltd, PTI quoted.Elsewhere in Asia, South Korea’s Kospi, Japan’s Nikkei 225, Shanghai’s SSE Composite index and Hong Kong’s Hang Seng index ended higher.European markets, however, were trading in the red, while US markets ended lower on Thursday.Foreign Institutional Investors (FIIs) sold equities worth Rs 3,752.52 crore on Thursday, while Domestic Institutional Investors (DIIs) purchased stocks worth Rs 5,153.37 crore, according to exchange data.On Thursday, the Sensex had rebounded 899.71 points, or 1.14 per cent, to settle at 80,015.90, snapping its four-day losing streak. The Nifty had climbed 285.40 points, or 1.17 per cent, to close at 24,765.90, ending its three-day decline.



Source link

Continue Reading

Business

Watch: How war in Iran may affect food and fuel prices

Published

on

Watch:  How war in Iran may affect food and fuel prices


As the US and Israel continue strikes on Iran, and with retaliatory strikes hitting nearby Middle East states, key shipping routes are being disrupted. Oil and gas production in the region is also being affected.

The BBC’s Nick Marsh examines how the war could cause a rise in living costs around the world.



Source link

Continue Reading

Business

Stock Market Updates: Sensex Tanks 1,100 Points, Nifty Tests 24,450; India VIX Jumps Over 11%

Published

on

Stock Market Updates: Sensex Tanks 1,100 Points, Nifty Tests 24,450; India VIX Jumps Over 11%


Last Updated:

The Nifty50 and the Sensex declined at open amid weak global cues.

Sensex Today

Sensex Today

Indian benchmark equity indices extended their losses in a volatile trading session on Friday as investors remained cautious amid escalating tensions in West Asia linked to the US-Iran conflict.

As of 3:19 PM, the Nifty50 was trading 1.21 per cent or 300 points down at 24,465, and the Sensex was trading 1,136 points or 1.42 per cent down at 78.879.

Market volatility spiked during the session, with the India VIX rising as much as 11.31% to 19.88.

Among Nifty50 constituents, InterGlobe Aviation, ICICI Bank, and Max Healthcare Institute were the top losers. On the other hand, Bharat Electronics Limited, Reliance Industries, and NTPC Limited were among the top gainers.

Broader markets also traded lower, with the Nifty Midcap 100 and Nifty Smallcap 100 declining 0.47% and 0.06%, respectively.

On the sectoral front, the Nifty IT Index was the only major gainer, rising 0.34% on the back of gains in Persistent Systems and Infosys.

Meanwhile, the Nifty Realty Index emerged as the worst-performing sector, falling nearly 2%, dragged down by losses in Godrej Properties, The Phoenix Mills, and Prestige Estates Projects.

The Nifty Private Bank Index and Nifty Financial Services Index were also among the major laggards during the session.

Global cues

Most markets across the Asia-Pacific region traded in the red as crude oil prices climbed amid rising concerns over supply disruptions linked to the escalating conflict involving the United States, Israel, and Iran.

In Asia, mainland China’s CSI 300 Index slipped around 0.1%, while South Korea’s Kospi Index declined 1.6%.

Overnight on Wall Street, the S&P 500 fell 0.57%, while the Dow Jones Industrial Average dropped 1.61%. The Nasdaq Composite ended 0.26% lower.

Market uncertainty also intensified after Letitia James and attorneys general from 23 US states reportedly filed another lawsuit seeking to block tariff measures announced by Donald Trump.

Oil and gold prices

Oil prices surged as traders remained concerned about potential supply disruptions. According to a Reuters report, Brent crude futures rose nearly 5% to $85.41 per barrel in the previous session.

During the Asian trading session, Brent Crude Oil was trading 0.15% higher at $84.16 per barrel.

Meanwhile, safe-haven demand pushed Gold Futures up 1.34% to $5,146.39, supported by ongoing geopolitical tensions.

Click here to add News18 as your preferred news source on Google.

Check Iran Israel War News Today Live Updates.

Follow News18 on Google. Join the fun, play games on News18. Stay updated with all the latest business news, including market trends, stock updates, tax, IPO, banking finance, real estate, savings and investments. To Get in-depth analysis, expert opinions, and real-time updates. Also Download the News18 App to stay updated.

News business markets Stock Market Updates: Sensex Tanks 1,100 Points, Nifty Tests 24,450; India VIX Jumps Over 11%
Disclaimer: Comments reflect users’ views, not News18’s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Read More



Source link

Continue Reading

Trending